Home › Funds › Point72 Asset Management › LFCR
Point72 Asset Management position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
Latest position (Q2 2026)52.52K sh
Reported value held$275.73K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 177.02K | $1.97M | New |
| Q1 2022 | 261.56K | $3.03M | Add |
| Q2 2022 | 203.70K | $2.03M | Reduce |
| Q3 2022 | 186.20K | $1.66M | Reduce |
| Q4 2022 | 141.45K | $916.57K | Reduce |
| Q4 2025 | 15.66K | $128.07K | New |
| Q1 2026 | 25.43K | $94.59K | Add |
| Q2 2026 | 52.52K | $275.73K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LFCR
- Vanguard Group 1.67M sh · $13.69M · Q4 2025
- BlackRock Inc 2.01M sh · $10.57M · Q2 2026
- Geode Capital Management 855.50K sh · $4.49M · Q2 2026
- Morgan Stanley 769.36K sh · $4.04M · Q2 2026
- Northern Trust Corp 253.82K sh · $1.33M · Q2 2026
- Marshall Wace 177.47K sh · $931.72K · Q2 2026
- Millennium Management 133.31K sh · $699.85K · Q2 2026
- Goldman Sachs Group 124.94K sh · $655.93K · Q2 2026
- Renaissance Technologies 104.86K sh · $550.51K · Q2 2026
- Citadel Advisors 98.87K sh · $519.07K · Q2 2026
- UBS Group AG 90.31K sh · $474.14K · Q2 2026
- Charles Schwab Investment Management 87.65K sh · $460.16K · Q2 2026